These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28457485)

  • 1. Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.
    Duncan WC; Slonena E; Hejazi NS; Brutsche N; Yu KC; Park L; Ballard ED; Zarate CA
    Biol Psychiatry; 2017 Sep; 82(5):361-369. PubMed ID: 28457485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
    Duncan WC; Slonena EE; Hejazi NS; Brutsche N; Park LT; Henter ID; Ballard ED; Zarate CA
    Neuropsychiatr Dis Treat; 2018; 14():2739-2748. PubMed ID: 30410340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.
    Duncan WC; Ballard ED; Zarate CA
    Handb Exp Pharmacol; 2019; 253():337-358. PubMed ID: 28939975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
    Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment-resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans.
    Zhuo C; Tian H; Li G; Chen M; Jiang D; Lin X; Xu Y; Wang W
    Brain Behav; 2019 Nov; 9(11):e01423. PubMed ID: 31617335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis.
    Wang M; Zhang B; Zhou Y; Wang C; Zheng W; Liu W; Zhan Y; Lan X; Ning Y
    Pharmacol Rep; 2021 Apr; 73(2):594-603. PubMed ID: 33387333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression.
    Ballard ED; Greenstein D; Reiss PT; Crainiceanu CM; Cui E; Duncan WC; Hejazi NS; Zarate CA
    Transl Psychiatry; 2024 Jun; 14(1):238. PubMed ID: 38834540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.
    Duncan WC; Selter J; Brutsche N; Sarasso S; Zarate CA
    J Affect Disord; 2013 Feb; 145(1):115-9. PubMed ID: 22871531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
    Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
    Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.
    Niciu MJ; Shovestul BJ; Jaso BA; Farmer C; Luckenbaugh DA; Brutsche NE; Park LT; Ballard ED; Zarate CA
    J Affect Disord; 2018 May; 232():310-315. PubMed ID: 29501990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adipokines in the rapid antidepressant effects of ketamine.
    Machado-Vieira R; Gold PW; Luckenbaugh DA; Ballard ED; Richards EM; Henter ID; De Sousa RT; Niciu MJ; Yuan P; Zarate CA
    Mol Psychiatry; 2017 Jan; 22(1):127-133. PubMed ID: 27046644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
    Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
    J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.
    Nugent AC; Wills KE; Gilbert JR; Zarate CA
    Psychiatry Res Neuroimaging; 2019 Jan; 283():64-66. PubMed ID: 30551012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine.
    Kohtala S; Alitalo O; Rosenholm M; Rozov S; Rantamäki T
    Pharmacol Ther; 2021 May; 221():107741. PubMed ID: 33189715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.
    Duncan WC; Sarasso S; Ferrarelli F; Selter J; Riedner BA; Hejazi NS; Yuan P; Brutsche N; Manji HK; Tononi G; Zarate CA
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):301-11. PubMed ID: 22676966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.